OrbiMed Capital GP VIII, Director: Kinnate Biopharma KNTE Buy · Filed 23/05/02

Trade details

Type: Insider buy
Amount: $583,322.7
Shares · price: 228,754 sh · $2.55 a share
Held after: 3,737,784 sh
Stock: Kinnate Biopharma KNTE
Person: OrbiMed Capital GP VIIIDirector
Trade date: 23/04/28
Filed: 23/05/02
Days to filing: 4 days

8 insiders bought this week

Insiders buying this week: 8 insiders
Holding change: +6.5%

Kinnate Biopharma trades, last 26 weeks

What else happened in Kinnate Biopharma around then

Filed or reported within 30 days of the trade day · 23/03/29~23/05/28

OrbiMed Capital GP VIII's recent trades

OrbiMed Capital GP VIIIDirector
Sell10b5-1 planSionna Therapeutics
Sell10b5-1 plan
Sionna Therapeutics
SION
$4,493
101 sh
$4,493
Filed 05/29
Traded 05/27
OrbiMed Capital GP VIIIDirector
Sell10b5-1 planSionna Therapeutics
Sell10b5-1 plan
Sionna Therapeutics
SION
$8.5M
184,639 sh
$8.5M
Filed 05/11
Traded 05/11
OrbiMed Capital GP VIIIDirector
Sell10b5-1 planSionna Therapeutics
Sell10b5-1 plan
Sionna Therapeutics
SION
$2.7M
59,767 sh
$2.7M
Filed 05/11
Traded 05/08
OrbiMed Capital GP VIIIDirector
Sell10b5-1 planSionna Therapeutics
Sell10b5-1 plan
Sionna Therapeutics
SION
$2.2M
48,546 sh
$2.2M
Filed 05/11
Traded 05/07
OrbiMed Capital GP VIII10% Owner
BuyTraws Pharma
Buy
Traws Pharma
TRAW
$998.2K
597,729 sh
$998.2K
Filed 04/28
Traded 04/16

OrbiMed Capital GP VIII, Director — bought $583.3K of Kinnate Biopharma KNTE · 228,754 sh @ $2.55 | Whalegun